Impedimed Accounts Payable vs Net Receivables Analysis

IPD Stock   0.05  0  2.00%   
Impedimed financial indicator trend analysis is infinitely more than just investigating Impedimed recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Impedimed is a good investment. Please check the relationship between Impedimed Accounts Payable and its Net Receivables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Accounts Payable vs Net Receivables

Accounts Payable vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Impedimed Accounts Payable account and Net Receivables. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Impedimed's Accounts Payable and Net Receivables is 0.48. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Impedimed, assuming nothing else is changed. The correlation between historical values of Impedimed's Accounts Payable and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Impedimed are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Accounts Payable i.e., Impedimed's Accounts Payable and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.48
Relationship DirectionPositive 
Relationship StrengthWeak

Accounts Payable

An accounting item on the balance sheet that represents Impedimed obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Impedimed are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Net Receivables

Most indicators from Impedimed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Impedimed current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Impedimed's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 40.3 K in 2024, whereas Discontinued Operations is likely to drop (120 K) in 2024.
 2021 2022 2023 2024 (projected)
Cost Of Revenue23.9M25.0M1.3M1.2M
Total Revenue10.6M11.3M10.3M5.2M

Impedimed fundamental ratios Correlations

0.00.20.30.60.28-0.410.430.630.10.620.260.280.680.280.120.980.34-0.93-0.460.940.31-0.150.940.660.37
0.00.940.050.260.220.630.360.18-0.540.320.890.180.030.0-0.240.090.03-0.07-0.10.070.13-0.060.070.110.11
0.20.940.130.520.40.470.580.4-0.570.510.970.350.270.08-0.310.250.15-0.2-0.310.210.27-0.230.210.340.27
0.30.050.130.030.66-0.110.610.56-0.470.110.30.910.580.940.270.250.87-0.05-0.790.090.960.350.090.420.95
0.60.260.520.030.53-0.260.480.660.060.790.490.220.590.0-0.340.540.03-0.52-0.50.520.2-0.290.520.660.24
0.280.220.40.660.53-0.310.730.85-0.380.630.50.760.790.65-0.010.150.640.01-0.940.010.770.010.010.760.76
-0.410.630.47-0.11-0.26-0.31-0.22-0.39-0.35-0.340.4-0.04-0.61-0.12-0.1-0.21-0.140.190.42-0.18-0.090.19-0.18-0.6-0.17
0.430.360.580.610.480.73-0.220.71-0.630.510.70.80.830.55-0.160.350.65-0.17-0.820.190.73-0.320.190.770.78
0.630.180.40.560.660.85-0.390.71-0.270.720.510.670.890.560.110.530.59-0.38-0.880.40.68-0.10.40.890.67
0.1-0.54-0.57-0.470.06-0.38-0.35-0.63-0.27-0.08-0.65-0.65-0.27-0.470.140.09-0.51-0.220.430.2-0.560.020.2-0.22-0.54
0.620.320.510.110.790.63-0.340.510.72-0.080.530.230.690.180.020.530.27-0.49-0.590.490.24-0.280.490.80.24
0.260.890.970.30.490.50.40.70.51-0.650.530.510.410.25-0.160.30.35-0.21-0.440.220.43-0.230.220.440.42
0.280.180.350.910.220.76-0.040.80.67-0.650.230.510.670.860.090.230.86-0.01-0.860.050.980.080.050.520.97
0.680.030.270.580.590.79-0.610.830.89-0.270.690.410.670.560.090.540.62-0.38-0.90.390.67-0.220.390.970.71
0.280.00.080.940.00.65-0.120.550.56-0.470.180.250.860.560.40.230.95-0.04-0.770.080.910.380.080.440.87
0.12-0.24-0.310.27-0.34-0.01-0.1-0.160.110.140.02-0.160.090.090.40.130.45-0.06-0.040.070.170.110.070.040.03
0.980.090.250.250.540.15-0.210.350.530.090.530.30.230.540.230.130.29-0.97-0.330.980.25-0.10.980.530.31
0.340.030.150.870.030.64-0.140.650.59-0.510.270.350.860.620.950.450.29-0.09-0.760.130.880.10.130.490.83
-0.93-0.07-0.2-0.05-0.520.010.19-0.17-0.38-0.22-0.49-0.21-0.01-0.38-0.04-0.06-0.97-0.090.15-1.0-0.040.11-1.0-0.4-0.1
-0.46-0.1-0.31-0.79-0.5-0.940.42-0.82-0.880.43-0.59-0.44-0.86-0.9-0.77-0.04-0.33-0.760.15-0.17-0.87-0.01-0.17-0.83-0.89
0.940.070.210.090.520.01-0.180.190.40.20.490.220.050.390.080.070.980.13-1.0-0.170.08-0.091.00.40.14
0.310.130.270.960.20.77-0.090.730.68-0.560.240.430.980.670.910.170.250.88-0.04-0.870.080.210.080.520.98
-0.15-0.06-0.230.35-0.290.010.19-0.32-0.10.02-0.28-0.230.08-0.220.380.11-0.10.10.11-0.01-0.090.21-0.09-0.210.19
0.940.070.210.090.520.01-0.180.190.40.20.490.220.050.390.080.070.980.13-1.0-0.171.00.08-0.090.40.14
0.660.110.340.420.660.76-0.60.770.89-0.220.80.440.520.970.440.040.530.49-0.4-0.830.40.52-0.210.40.56
0.370.110.270.950.240.76-0.170.780.67-0.540.240.420.970.710.870.030.310.83-0.1-0.890.140.980.190.140.56
Click cells to compare fundamentals

Impedimed Account Relationship Matchups

Impedimed fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets33.1M34.2M58.7M68.7M47.0M37.4M
Other Current Liab2.3M5.6M3.5M3.2M3.2M3.0M
Total Current Liabilities5.1M8.1M7.2M5.8M4.7M4.8M
Other Liab87K398K413K864K993.6K1.0M
Accounts Payable1.9M1.3M2.6M1.4M1.1M1.4M
Net Receivables1.7M2.8M2.7M2.6M2.2M1.4M
Good Will2.6M2.4M2.6M2.7M2.7M2.5M
Inventory864K372K926K810K759K912.9K
Other Current Assets3.3M2.8M2.3M2.8M1.9M1.7M
Total Liab5.7M8.7M7.7M7.9M6.2M5.2M
Intangible Assets6.5M7.5M11.4M14.8M13.3M14.0M
Common Stock250.6M267.3M307.6M336.1M336.1M185.5M
Property Plant Equipment1.0M1.0M418K2.0M2.2M2.4M
Total Stockholder Equity27.4M25.5M51.0M60.9M40.7M34.4M
Property Plant And Equipment Net1.0M1.0M418K2.0M1.4M1.5M
Net Debt(18.8M)(19.2M)(40.6M)(44.3M)(23.5M)(24.7M)
Retained Earnings(250.1M)(270.8M)(290.6M)(311.2M)(331.0M)(314.4M)
Cash19.7M19.7M40.7M45.7M24.6M28.3M
Non Current Assets Total7.6M8.6M12.0M16.8M17.5M18.4M
Non Currrent Assets Other(7.6M)(8.6M)(11.9M)(16.8M)13.3M14.0M
Cash And Short Term Investments19.7M19.7M40.7M45.7M24.6M28.3M
Common Stock Shares Outstanding595.2M1.2B1.7B1.8B2.0B2.1B
Liabilities And Stockholders Equity33.1M34.2M58.7M68.7M47.0M39.2M
Non Current Liabilities Total594K557K413K2.0M1.6M1.7M
Property Plant And Equipment Gross1.0M3.4M3.8M5.6M5.7M5.9M
Total Current Assets25.5M25.7M46.7M51.9M29.5M32.8M
Accumulated Other Comprehensive Income26.9M29.0M34.1M36.0M35.5M37.3M
Short Term Debt364K(562K)(758K)141.0K333K349.7K
Net Tangible Assets20.8M18.1M39.7M46.1M41.5M28.0M
Current Deferred Revenue578K877K928K1.0M1.5M1.6M
Long Term Investments77K73K75K78K54K62.5K
Net Invested Capital27.4M25.5M51.0M60.9M40.7M43.5M
Cash And Equivalents8.8M11.5M31.3M13.5M12.2M17.0M
Net Working Capital20.3M17.5M39.4M46.1M24.8M24.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Impedimed Stock Analysis

When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.